Categories: New Launches

Trivitron Introduces COVIDscreen Plus ELISA Test kit for Antibody Testing of COVID-19

New Delhi, July 21, 2020: Ace health technology organization, Trivitron Healthcare introduces COVIDscreen Plus, an indigenously developed & manufactured ELISA test kit for the diagnosis of COVID-19 infection. The kit is designed for the qualitative detection of SARS-CoV-2 IgG, IgM and IgA antibodies. COVIDscreen Plus is approved and validated by the Indian Council of Medical Research (ICMR).

COVIDscreen Plus guarantees high diagnostic value as it offers 100% sensitivity and 99% specificity. The kit is based on the double antigen sandwich ELISA technique and makes use of blood serum/blood plasma as a sample.

The Elisa test kit, though needs to be handled by a trained or an experienced professional, offers ease-of-use to facilitate swift action and hassle-free use. The Elisa test kit features world-class quality and comes with color-coded reagents so that it can be easily identified by the laboratory technician. This feature not only saves time but also nullifies the possibility of operational errors.

COVIDscreen Plus uses high purity reagents with enhanced reactivity which considerably lowers its incubation time and offers prompt results. This Elisa test kit is intended to play a pivotal role in the mass screening of COVID-19 by all kinds of laboratories in the country. The affordable price per test of COVIDscreen Plus ELISA test kit will ensure greater acceptance, accessibility, and shall facilitate testing for one and all.

“COVIDscreen Plus is the latest entrant in COVID diagnostic kits and has been developed under the Make in India initiative. The Elisa test kit offers high diagnostics value through enhanced sensitivity & specificity and is affordable as compared to otherCOVID RT PCR diagnostic kits available in the market.” said Mr. Rajesh Patel, CEO-IVD (India) Trivitron Healthcare.

In view of the ICMR’s latest decision of allowing COVID-19 testing in all the laboratories, Trivitron’s COVIDscreen Plus ELISA test kit comes with unique ‘break apart’ wells that offers flexibility so that it can be used by large, medium &small-scale laboratories. Additionally, COVIDscreen Plus is packed in convenient pack size (96 tests per pack) and has a higher shelf life of 15 months (at specified storage conditions) that makes it an ideal testing kit for hospitals, in-house healthcare settings, clinics & laboratories, and it is perfectly fit for inter-state, &overseas transportation.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

1 day ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

1 day ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

2 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

2 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

3 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

3 days ago